126 related articles for article (PubMed ID: 35730330)
21. Prognostic value of pretreatment Glasgow prognostic score in stage IIIB geriatric non-small cell lung cancer patients undergoing radical chemoradiotherapy.
Topkan E; Bolukbasi Y; Ozdemir Y; Besen AA; Mertsoylu H; Selek U
J Geriatr Oncol; 2019 Jul; 10(4):567-572. PubMed ID: 31178158
[TBL] [Abstract][Full Text] [Related]
22. Prognostic significance of the preoperative C-reactive protein-to-albumin ratio in patients with colorectal cancer.
Tamagawa H; Aoyama T; Numata M; Maezawa Y; Kazama K; Astumi Y; Hara K; Kano K; Yukawa N; Saeki H; Godai T; Oshima T; Goda M; Rino Y; Masuda M
J Cancer Res Ther; 2021; 17(4):1075-1080. PubMed ID: 34528567
[TBL] [Abstract][Full Text] [Related]
23. Elevated serum C-reactive protein, carcinoembryonic antigen and N2 disease are poor prognostic indicators in non-small cell lung cancer.
Ni XF; Wu P; Wu CP; Ji M; Wu J; Gu XF; Jiang ZX
Asia Pac J Clin Oncol; 2015 Dec; 11(4):e22-30. PubMed ID: 24889374
[TBL] [Abstract][Full Text] [Related]
24. Identification of the Best Prognostic Marker Among Immunonutritional Parameters Using Serum C-Reactive Protein and Albumin in Non-Small Cell Lung Cancer.
Matsubara T; Takamori S; Haratake N; Fujishita T; Toyozawa R; Ito K; Shimokawa M; Yamaguchi M; Seto T; Okamoto T
Ann Surg Oncol; 2021 Jun; 28(6):3046-3054. PubMed ID: 33084992
[TBL] [Abstract][Full Text] [Related]
25. Ratio of C-reactive protein to albumin is a prognostic factor for operable non-small-cell lung cancer in elderly patients.
Miyazaki T; Yamasaki N; Tsuchiya T; Matsumoto K; Kunizaki M; Kamohara R; Hatachi G; Doi R; Obata T; Nagayasu T
Surg Today; 2017 Jul; 47(7):836-843. PubMed ID: 27853867
[TBL] [Abstract][Full Text] [Related]
26. [C-reactive protein/albumin ratio as a novel inflammation-based prognostic index for predicting outcomes of patients with colorectal cancer].
Chen YY; Zhang JH; Zhang W; Yang ZK; Luo RC; Kang SJ
Nan Fang Yi Ke Da Xue Xue Bao; 2017 May; 37(5):622-627. PubMed ID: 28539284
[TBL] [Abstract][Full Text] [Related]
27. Postoperative C-reactive protein/albumin ratio is a biomarker of risk of recurrence and need for adjuvant chemotherapy for stage III colorectal cancer.
Matsuoka H; Ando K; Hu Q; Zaitsu Y; Tsuda Y; Hisamatsu Y; Nakashima Y; Kimura Y; Oki E; Mori M
Int J Clin Oncol; 2020 Jul; 25(7):1318-1326. PubMed ID: 32279124
[TBL] [Abstract][Full Text] [Related]
28. Advanced Lung Cancer Inflammation Index Predicts Outcomes of Patients with Pathological Stage IA Lung Adenocarcinoma Following Surgical Resection.
Kobayashi S; Karube Y; Inoue T; Araki O; Maeda S; Matsumura Y; Chida M
Ann Thorac Cardiovasc Surg; 2019 Apr; 25(2):87-94. PubMed ID: 30333361
[TBL] [Abstract][Full Text] [Related]
29. Prognostic significance of inflammatory response markers for locally advanced squamous cell carcinoma of the external auditory canal and middle ear.
Makita K; Hamamoto Y; Takata N; Ishikawa H; Tsuruoka S; Uwatsu K; Hato N; Kido T
J Radiat Res; 2021 Jul; 62(4):662-668. PubMed ID: 34115873
[TBL] [Abstract][Full Text] [Related]
30. Predicting the recurrence risk factors and clinical outcomes of peripheral pulmonary adenocarcinoma ≤3 cm with wedge resection.
Wang Y; Wang R; Zheng D; Han B; Zhang J; Zhao H; Luo J; Zheng J; Chen T; Huang Q; Sun Y; Chen H
J Cancer Res Clin Oncol; 2017 Jun; 143(6):1043-1051. PubMed ID: 28204972
[TBL] [Abstract][Full Text] [Related]
31. Prognostic Significance of the Preoperative Ratio of C-Reactive Protein to Albumin and Neutrophil-Lymphocyte Ratio in Gastric Cancer Patients.
Saito H; Kono Y; Murakami Y; Shishido Y; Kuroda H; Matsunaga T; Fukumoto Y; Osaki T; Ashida K; Fujiwara Y
World J Surg; 2018 Jun; 42(6):1819-1825. PubMed ID: 29270656
[TBL] [Abstract][Full Text] [Related]
32. Prognostic impact of preoperative monocyte counts in patients with resected lung adenocarcinoma.
Kumagai S; Marumo S; Shoji T; Sakuramoto M; Hirai T; Nishimura T; Arima N; Fukui M; Huang CL
Lung Cancer; 2014 Sep; 85(3):457-64. PubMed ID: 25043641
[TBL] [Abstract][Full Text] [Related]
33. C-reactive protein/albumin ratio predicts survival after curative surgery in elderly patients with colorectal cancer.
Tamai K; Okamura S; Makino S; Yamamura N; Fukuchi N; Ebisui C; Inoue A; Yano M
Updates Surg; 2022 Feb; 74(1):153-162. PubMed ID: 33677820
[TBL] [Abstract][Full Text] [Related]
34. Clinical value of C-reactive protein/albumin ratio in Guillain-Barré syndrome.
Ning P; Yang B; Yang X; Huang H; Shen Q; Zhao Q; Lu H; Yang L; Tian S; Xu Y
Neurol Sci; 2021 Aug; 42(8):3275-3283. PubMed ID: 33247320
[TBL] [Abstract][Full Text] [Related]
35. Association between the C-reactive protein/albumin ratio and prognosis in patients with oral squamous cell carcinoma.
Yamagata K; Fukuzawa S; Ishibashi-Kanno N; Uchida F; Bukawa H
Sci Rep; 2021 Mar; 11(1):5446. PubMed ID: 33686103
[TBL] [Abstract][Full Text] [Related]
36. C reactive protein to albumin ratio (CAR) as predictor of anastomotic leakage in colorectal surgery.
Paliogiannis P; Deidda S; Maslyankov S; Paycheva T; Farag A; Mashhour A; Misiakos E; Papakonstantinou D; Mik M; Losinska J; Scognamillo F; Sanna F; Feo CF; Porcu A; Xidas A; Zinellu A; Restivo A; Zorcolo L
Surg Oncol; 2021 Sep; 38():101621. PubMed ID: 34126521
[TBL] [Abstract][Full Text] [Related]
37. Can D3 Lymph Node Dissection for Patients With Colon Cancer With a Poor C-Reactive Protein/Albumin Ratio Improve Survival Outcomes?
Atsumi Y; Numata M; Kazama K; Kawahara S; Ju M; Iguchi K; Sawazaki S; Aoyama T; Tamagawa A; Sato S; Higuchi A; Sugano N; Godai T; Tamagawa H; Saeki H; Oshima T; Shiozawa M; Yukawa N; Rino Y
Anticancer Res; 2021 Oct; 41(10):5097-5106. PubMed ID: 34593460
[TBL] [Abstract][Full Text] [Related]
38. Neutrophil gelatinase-associated lipocalin (NGAL) and matrix metalloproteinase-9 (MMP-9) prognostic value in lung adenocarcinoma.
Ruiz-Morales JM; Dorantes-Heredia R; Arrieta O; Chávez-Tapia NC; Motola-Kuba D
Tumour Biol; 2015 May; 36(5):3601-10. PubMed ID: 25542236
[TBL] [Abstract][Full Text] [Related]
39. NLR and CRP to albumin ratio as a predictor of in-hospital mortality in the geriatric ED patients.
Ayrancı MK; Küçükceran K; Dundar ZD
Am J Emerg Med; 2021 Jun; 44():50-55. PubMed ID: 33578332
[TBL] [Abstract][Full Text] [Related]
40. [Prognostic study of visceral pleural invasion by pulmonary adenocarcinoma with tumor size ≤3 cm].
Chen TY; Ma HW; Jin RR; Xu C; Hua HJ; Song GX; Zhang WM; Zhang ZH
Zhonghua Bing Li Xue Za Zhi; 2017 Aug; 46(8):553-558. PubMed ID: 28810296
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
